133 related articles for article (PubMed ID: 10517116)
1. [Increased thrombin time in a patient with multiple myeloma].
Bohler A; Redondo M; Lämmle B
Ther Umsch; 1999 Sep; 56(9):491-4. PubMed ID: 10517116
[TBL] [Abstract][Full Text] [Related]
2. [Unexpectedly prolonged thrombin time].
Barth A; Furlan M; Lämmle B
Schweiz Med Wochenschr; 1993 Mar; 123(12):523-9. PubMed ID: 8475358
[TBL] [Abstract][Full Text] [Related]
3. [Disorders in the conversion of fibrinogen to fibrin in patients with multiple myeloma].
Lopaciuk S; Snigurowicz J; Rostkowska J; Pniejnia-Olszyński W; Powiertowska-Rezmer M
Acta Haematol Pol; 1978; 9(3):157-64. PubMed ID: 102100
[TBL] [Abstract][Full Text] [Related]
4. Acquired dysfibrinogenemia secondary to multiple myeloma.
Kotlín R; Sobotková A; Riedel T; Salaj P; Suttnar J; Reicheltová Z; Májek P; Khaznadar T; Dyr JE
Acta Haematol; 2008; 120(2):75-81. PubMed ID: 18841003
[TBL] [Abstract][Full Text] [Related]
5. An acquired cryoglobulinemia which inhibits fibrin polymerization in a patient with IgG kappa myeloma.
Panzer S; Thaler E
Haemostasis; 1993; 23(1):69-76. PubMed ID: 8477911
[TBL] [Abstract][Full Text] [Related]
6. Bleeding diathesis in multiple myeloma.
Saif MW; Allegra CJ; Greenberg B
J Hematother Stem Cell Res; 2001 Oct; 10(5):657-60. PubMed ID: 11672511
[TBL] [Abstract][Full Text] [Related]
7. Gamma globulin inhibition of fibrin clot formation.
Davey FR; Gordon GB; Boral LI; Gottlieb AJ
Ann Clin Lab Sci; 1976; 6(1):72-7. PubMed ID: 1247286
[TBL] [Abstract][Full Text] [Related]
8. Acquired Dysfibrinogenemia Caused by Autoantibody Inhibiting Fibrin Polymerization in a Patient with MELAS Syndrome and Bleeding Tendency.
Lee N; Kim JE; Yoo HJ; Gu J; Kim H; Chung J; Koh Y; Kim HK
Ann Clin Lab Sci; 2016 Dec; 46(6):696-700. PubMed ID: 27993886
[TBL] [Abstract][Full Text] [Related]
9. Acquired dysfibrinogenemia secondary to mithramycin toxicity.
Ashby MA; Lazarchick J
Am J Med Sci; 1986 Jul; 292(1):53-5. PubMed ID: 2940861
[TBL] [Abstract][Full Text] [Related]
10. Identification of a monoclonal thrombin inhibitor associated with multiple myeloma and a severe bleeding disorder.
Colwell NS; Tollefsen DM; Blinder MA
Br J Haematol; 1997 Apr; 97(1):219-26. PubMed ID: 9136969
[TBL] [Abstract][Full Text] [Related]
11. Heparin-like anticoagulant associated with plasma cell myeloma.
Chapman GS; George CB; Danley DL
Am J Clin Pathol; 1985 Jun; 83(6):764-6. PubMed ID: 3923825
[TBL] [Abstract][Full Text] [Related]
12. The importance of simple coagulation tests (fibrinogen assays and thrombin coagulase clotting time) in the diagnosis of liver cancer.
Pengo V; Levi Minzi S; Dal Bo Zanon R; Cappellato G; Farinati F; Girolami A
J Med; 1984; 15(2):149-60. PubMed ID: 6096471
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of fibrin monomer polymerisation by myeloma immunoglobulin.
O'Kane MJ; Wisdom GB; Desai ZR; Archbold GP
J Clin Pathol; 1994 Mar; 47(3):266-8. PubMed ID: 8163700
[TBL] [Abstract][Full Text] [Related]
14. Elevated fibrinogen in an acute phase reaction prolongs the reptilase time but typically not the thrombin time.
Van Cott EM; Smith EY; Galanakis DK
Am J Clin Pathol; 2002 Aug; 118(2):263-8. PubMed ID: 12162688
[TBL] [Abstract][Full Text] [Related]
15. [Acquired dysfibrinogenemia in a child in the course of a liver disease].
Maak B; Meyer M; Dietze H
Monatsschr Kinderheilkd; 1990 Aug; 138(8):446-50. PubMed ID: 2215508
[TBL] [Abstract][Full Text] [Related]
16. Fibrin polymerization defect in HIV-infected patients--evidence for a critical role of albumin in the prolongation of thrombin and reptilase clotting times.
Toulon P; Frere E; Bachmeyer C; Candia N; Blanche P; Sereni D; Sicard D
Thromb Haemost; 1995 Mar; 73(3):349-55. PubMed ID: 7667815
[TBL] [Abstract][Full Text] [Related]
17. A case of acquired dysfibrinogenemia in multiple myeloma treated with therapeutic plasma exchange.
Post GR; James L; Alapat D; Guillory V; Cottler-Fox M; Nakagawa M
Transfus Apher Sci; 2013 Feb; 48(1):35-8. PubMed ID: 22842111
[TBL] [Abstract][Full Text] [Related]
18. [Hypodysfibrinogenemia: fibrinogen giessen II (author's transl)].
Krause WH; Huth K; Heene DL; Lasch HG
Klin Wochenschr; 1975 Aug; 53(16):781-2. PubMed ID: 1165625
[TBL] [Abstract][Full Text] [Related]
19. Acquired dysfibrinogenemia caused by monoclonal production of immunoglobulin lambda light chain.
Dear A; Brennan SO; Sheat MJ; Faed JM; George PM
Haematologica; 2007 Nov; 92(11):e111-7. PubMed ID: 18024387
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen Nový Jicín and Praha II: cases of hereditary Aalpha 16 Arg-->Cys and Aalpha 16 Arg-->His dysfibrinogenemia.
Kotlín R; Chytilová M; Suttnar J; Riedel T; Salaj P; Blatný J; Santrůcek J; Klener P; Dyr JE
Thromb Res; 2007; 121(1):75-84. PubMed ID: 17408725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
